13F-HR filed by SILVERARC CAPITAL MANAGEMENT, LLC
SILVERARC CAPITAL MANAGEMENT, LLC filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-05-15, with 72 holding rows worth $242,254,307.
- Accession
- 0001420506-23-001081
- Filer
- CIK 1816307
- Filed
- 2023-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2023
A holdings report, 72 entries on the cover page, a total value of $242,254,307 stated on the cover page (in dollars after the unit check, H1), rows summing to $242,254,307 with VALUE read as dollars as filed, 13F file number 028-21010. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerSilverArc Capital, LLC 028-20993
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MERUS N V | N5749R100 | COM | 668,784 | $12,305,626 | dollars as filed | |
| MACROGENICS INC | 556099109 | COM | 1,361,809 | $9,764,171 | dollars as filed | |
| Viewra, Inc | 92672L107 | COM | 2,793,748 | $9,666,368 | dollars as filed | |
| POSEIDA THERAPEUTICS INC | 73730P108 | COM | 2,689,301 | $8,283,047 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 1,435,945 | $8,184,887 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 667,922 | $7,908,196 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 202,561 | $7,749,984 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 281,533 | $7,345,196 | dollars as filed | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 1,000,000 | $7,200,000 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 125,035 | $6,770,645 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 438,215 | $6,674,014 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 380,000 | $6,327,000 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 579,264 | $6,250,259 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 1,541,426 | $5,996,147 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 723,544 | $5,687,056 | dollars as filed | |
| SCHRODINGER INC COM | 80810D103 | Stock | 212,825 | $5,603,682 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 199,600 | $5,309,360 | dollars as filed | call |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 651,400 | $5,269,826 | dollars as filed | call |
| Gilead Sciences,Inc. | 375558103 | COM | 60,130 | $4,988,986 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 577,757 | $4,818,493 | dollars as filed | |
| VERACYTE INC COM | 92337F107 | Stock | 209,653 | $4,675,262 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 559,387 | $4,505,862 | dollars as filed | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 1,128,200 | $4,332,288 | dollars as filed | call |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 18,578 | $4,160,729 | dollars as filed | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 13,181 | $4,152,938 | dollars as filed | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 5,000 | $4,108,350 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 96,643 | $3,458,853 | dollars as filed | |
| CERUS CORP | 157085101 | COM | 1,152,902 | $3,424,119 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 11,311 | $3,144,797 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 200,000 | $3,046,000 | dollars as filed | call |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 84,651 | $3,045,743 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 14,043 | $2,813,094 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 34,014 | $2,723,161 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 265,032 | $2,711,277 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 100,000 | $2,660,000 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 105,939 | $2,544,655 | dollars as filed | |
| INCYTE CORP COM | 45337C102 | Stock | 33,938 | $2,452,699 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 143,794 | $2,451,688 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 105,486 | $2,426,178 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 10,000 | $2,422,600 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 70,000 | $2,345,000 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 105,750 | $2,261,993 | dollars as filed | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 540,059 | $2,219,642 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 282,432 | $1,948,781 | dollars as filed | |
| MORPHIC HLDG INC | 61775R105 | COM | 51,684 | $1,945,386 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 220,100 | $1,780,609 | dollars as filed | |
| ALTIMMUNE INC | 02155H200 | COM NEW | 415,700 | $1,754,254 | dollars as filed | call |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 885,924 | $1,638,959 | dollars as filed | |
| PROMETHEUS BIOSCIENCES INC | 74349U108 | COM | 13,921 | $1,494,002 | dollars as filed | |
| POINT BIOPHARMA GLOBAL INC | 730541109 | COM | 198,477 | $1,442,928 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 200,000 | $1,428,000 | dollars as filed | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 37,858 | $1,410,968 | dollars as filed | |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 485,955 | $1,409,270 | dollars as filed | |
| SERES THERAPEUTICS INC | 81750R102 | COM | 232,525 | $1,318,417 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 9,270 | $1,277,684 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 93,823 | $1,247,846 | dollars as filed | |
| CUE BIOPHARMA INC | 22978P106 | COM | 306,278 | $1,093,412 | dollars as filed | |
| ALLAKOS INC | 01671P100 | COM | 211,010 | $938,995 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 36,381 | $925,533 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871103 | COM | 500,000 | $905,000 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 40,000 | $663,200 | dollars as filed | |
| ACUMEN PHARMACEUTICALS INC | 00509G209 | CMN | 146,922 | $596,503 | dollars as filed | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 150,000 | $576,000 | dollars as filed | |
| TELA BIO INC | 872381108 | COM | 54,096 | $575,581 | dollars as filed | |
| ALIGOS THERAPEUTICS INC COM NEW | 01626L105 | Stock | 631,887 | $552,269 | dollars as filed | |
| CVRX INC | 126638105 | COMMON STOCK | 30,000 | $279,600 | dollars as filed | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 31,156 | $242,705 | dollars as filed | |
| LAVA THERAPEUTICS NV | N51517105 | SHS | 140,291 | $232,883 | dollars as filed | |
| COMPUGEN LTD | M25722105 | ORD | 330,188 | $231,792 | dollars as filed | |
| ELOXX PHARMACEUTICALS INC NEW | 29014R202 | Com | 54,075 | $135,728 | dollars as filed | |
| Rocket Pharmaceuticals Inc W Exp 09/02/202 | 77313F114 | Warrant | 104,828 | $11,531 | dollars as filed | |
| FRESH TRACKS THERAPEUTICS INC | 10802T204 | Com | 10,000 | $6,600 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-23-001081 | this filing | 2023-05-15 | acceptance time not in the bulk data set |